Tech Company Financing Transactions
Knopp Biosciences Funding Round
Knopp Biosciences, based in Pittsburgh, scored $6.6 million from Kramer Capital Partners, LaunchCyte and private investors.
Transaction Overview
Company Name
Announced On
11/19/2008
Transaction Type
Venture Equity
Amount
$6,600,000
Round
Series B
Investors
Proceeds Purpose
Proceeds from the offering will be used to advance Knopp's discovery research targeting mitochondrial mechanisms of neurodegeneration and to complete an ongoing Phase 2 study of KNS-760704 in amyotrophic lateral sclerosis (ALS).
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2100 Wharton St. 615
Pittsburgh, PA 15203
USA
Pittsburgh, PA 15203
USA
Phone
Website
Email Address
Overview
Knopp Bioosciences Inc. is a Pittsburgh-based biotechnology company dedicated to developing novel biomarkers and drug therapies for amyotrophic lateral sclerosis (ALS).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Bozik
VP - Bus. Development
Thomas Petzinger
VP - Operations
Gregory Hebrank
VP - R & D
Calman Prussin
VP - Regulatory Affairs
Mary Sullivan
Browse more venture capital transactions:
Prev: 11/19/2008: Tengion venture capital transaction
Next: 11/20/2008: MicroPhage venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs